Skye Bioscience, Inc. (SKYE)
1.765
0.00 (0.00%)
USD |
NASDAQ |
Sep 21, 16:00
1.84
+0.08
(+4.25%)
After-Hours: 20:00
Skye Bioscience Market Cap : 7.754M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 7.754M |
| September 17, 2026 | 6.897M |
| September 16, 2026 | 7.468M |
| September 15, 2026 | 9.269M |
| September 14, 2026 | 8.742M |
| September 11, 2026 | 8.962M |
| September 10, 2026 | 9.137M |
| September 09, 2026 | 9.796M |
| September 08, 2026 | 8.259M |
| September 04, 2026 | 8.171M |
| September 03, 2026 | 7.820M |
| September 02, 2026 | 8.083M |
| September 01, 2026 | 7.907M |
| August 31, 2026 | 7.380M |
| August 28, 2026 | 7.798M |
| August 27, 2026 | 8.566M |
| August 26, 2026 | 8.874M |
| August 25, 2026 | 8.852M |
| August 24, 2026 | 9.533M |
| August 21, 2026 | 9.840M |
| August 20, 2026 | 9.854M |
| August 19, 2026 | 10.75M |
| August 18, 2026 | 100.93M |
| August 17, 2026 | 116.71M |
| August 14, 2026 | 141.00M |
| Date | Value |
|---|---|
| August 13, 2026 | 152.10M |
| August 12, 2026 | 154.32M |
| August 11, 2026 | 152.07M |
| August 10, 2026 | 149.71M |
| August 07, 2026 | 146.03M |
| August 06, 2026 | 132.62M |
| August 05, 2026 | 157.92M |
| August 04, 2026 | 161.66M |
| August 03, 2026 | 164.25M |
| July 31, 2026 | 159.83M |
| July 30, 2026 | 163.15M |
| July 29, 2026 | 172.91M |
| July 28, 2026 | 172.88M |
| July 27, 2026 | 175.10M |
| July 24, 2026 | 183.28M |
| July 23, 2026 | 189.78M |
| July 22, 2026 | 179.99M |
| July 21, 2026 | 179.94M |
| July 20, 2026 | 183.79M |
| July 17, 2026 | 182.55M |
| July 16, 2026 | 176.73M |
| July 15, 2026 | 170.40M |
| July 14, 2026 | 174.34M |
| July 13, 2026 | 186.12M |
| July 10, 2026 | 193.99M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 82.55B |
| Viking Therapeutics, Inc. | 3.515B |
| ACADIA Pharmaceuticals, Inc. | 4.543B |
| Alnylam Pharmaceuticals, Inc. | 32.66B |
| Anika Therapeutics, Inc. | 277.30M |
Market Cap Related Metrics
| PEG Ratio | -0.0091 |
| Price | 1.765 |
| Earnings Yield | -576.8% |
| PEGY Ratio | -0.0091 |